article 3 months old

Australian Broker Call *Extra* Edition – Nov 01, 2023

Daily Market Reports | Nov 01 2023

This story features 29METALS LIMITED, and other companies. For more info SHARE ANALYSIS: 29M

An additional news report on the recommendation, valuation, forecast and opinion changes and updates for ASX-listed equities.

In addition to The Australian Broker Call Report, which is published and updated daily (Mon-Fri), FNArena has now added The Australian Broker Call *Extra* Edition, featuring additional sources of research and insights on ASX-listed stocks, also enlarging the number of stocks that make up the FNArena universe.

One key difference is the *Extra* Edition will not be updated daily, but merely "regularly" depending on availability of suitable quality content. As such, the *Extra* Edition tries to build a bridge between daily updates via the Australian Broker Call Report and ad hoc news stories, that are not always timely for investors hungry for the next information update.

Investors using the *Extra* Edition as a source of input for their own share market research should thus take into account that information after publication may not be up to date, or yet awaiting another update by FNArena's team of journalists.

Similar to The Australian Broker Call Report, this *Extra* Edition includes concise but limited reviews of research recently published by Stockbrokers and other experts, which should be considered as information concerning likely market behaviour rather than advice on the securities mentioned. Do not act on the contents of this Report without first reading the important information included at the end of this Report.

The Australian Broker Call *Extra* Edition is a summary that has been prepared independently of the sources identified. Readers will check the full text of the recommendations and consult a Licenced Advisor before making any investment decision.

The copyright of this Report is owned by the publisher. Readers will not copy, forward or disseminate this Report to any other person. For more vital information about the sources included, see the bottom of this Report.

COMPANIES DISCUSSED IN THIS ISSUE

Click on a symbol for fast access.
The number next to the symbol represents the number of brokers covering it for this report -(if more than 1)

29M   AND   BPT (2)   CCP   CXL   EVS   KGN   KLS   MFG   MIN (2)   MPL   NHF   PBH   PME   PRU   QBE   REG   RGN   SUL (3)   WOW (2)  

29M    29METALS LIMITED

Copper – Overnight Price: $0.62

Jarden rates ((29M)) as Overweight (2) –

29Metals September-quarter copper  production met Jarden's forecasts but zinc production disappointed. Sales fell shy of the broker's forecasts. Management retained guidance.

The company closed the quarter with $227m in cash and net debt of $15m.

Jarden observes leading indicators at Golden Grove are positive, noting completion of ventilation works should put an end to bottlenecks, enabling stronger ore extraction rates.

Capricorn Copper's recovery is under way, but the broker doubts it will be an easy ride.

Overweight rating retained, the broker observing the company is trading at more than -30% below Jarden's valuation. Target price edges up to 82c from 80c to reflect a beat on capital expenditure at Capricorn Copper.

This report was published on October 26, 2023.

Target price is $0.82 Current Price is $0.62 Difference: $0.2
If 29M meets the Jarden target it will return approximately 32% (excluding dividends, fees and charges).
Current consensus price target is $0.83, suggesting upside of 37.5%(ex-dividends)
The company's fiscal year ends in December.

Forecast for FY23:

Jarden forecasts a full year FY23 dividend of 0.00 cents and EPS of minus 20.80 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is minus 2.98.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is -20.3, implying annual growth of N/A.
Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A.
Current consensus EPS estimate suggests the PER is N/A.

Forecast for FY24:

Jarden forecasts a full year FY24 dividend of 0.00 cents and EPS of minus 3.80 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is minus 16.32.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is -8.4, implying annual growth of N/A.
Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A.
Current consensus EPS estimate suggests the PER is N/A.

Market Sentiment: 0.5
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

AND    ANSARADA GROUP LIMITED

Software & Services – Overnight Price: $1.43

Canaccord Genuity rates ((AND)) as Buy (1) –

Following a 1Q run-rate for revenue ahead of Canaccord Genuity's 1H forecast, the broker believes Ansarada Group is in the early stages of an earnings upgrade cycle.

The broker expects future revenue growth given deferred revenue increased by 10% quarter-on-quarter to $18.6m and is now at record levels. Growth for customer additions in the quarter illustrates latent demand for the company's platform, in the analysts' view.

Strong earnings leverage into FY25 is likely, according to Canaccord, thanks not only to deferred revenue but also price rises in October and ongoing growth in active customers.

The Buy rating and $2.00 target are maintained.

This report was published on October 25, 2023.

Target price is $2.00 Current Price is $1.43 Difference: $0.57
If AND meets the Canaccord Genuity target it will return approximately 40% (excluding dividends, fees and charges).
The company's fiscal year ends in June.

Forecast for FY24:

Canaccord Genuity forecasts a full year FY24 dividend of 0.00 cents and EPS of 2.10 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 68.10.

Forecast for FY25:

Canaccord Genuity forecasts a full year FY25 dividend of 0.00 cents and EPS of 5.40 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 26.48.

Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

BPT    BEACH ENERGY LIMITED

Crude Oil – Overnight Price: $1.54

Jarden rates ((BPT)) as Overweight (2) –

Beach Energy's September-quarter production met Jarden's forecasts, albeit on a -10% fall in quarterly productions due to low customer nominations at Otway.

The company highlighted Origin Energy in this respect, and the broker believes this points to a more challenging relationship going forward, which could result in arbitration as part of the gas price review.

Wilsons expects the trend will continue out to December but that output will improve in 2024.

EPS forecasts fall -9.5% in FY24; and -1.8% in FY25. DPS forecasts fall -15.4% and -3.4% respectively.

Overweight rating and $1.85 target price retained.

This report was published on October 26, 2023.

Target price is $1.85 Current Price is $1.54 Difference: $0.305
If BPT meets the Jarden target it will return approximately 20% (excluding dividends, fees and charges).
Current consensus price target is $1.79, suggesting upside of 15.8%(ex-dividends)
The company's fiscal year ends in June.

Forecast for FY24:

Jarden forecasts a full year FY24 dividend of 5.50 cents and EPS of 18.00 cents.
At the last closing share price the estimated dividend yield is 3.56%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 8.58.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 17.8, implying annual growth of 1.3%.
Current consensus DPS estimate is 4.5, implying a prospective dividend yield of 2.9%.
Current consensus EPS estimate suggests the PER is 8.7.

Forecast for FY25:

Jarden forecasts a full year FY25 dividend of 14.00 cents and EPS of 32.00 cents.
At the last closing share price the estimated dividend yield is 9.06%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 4.83.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 27.0, implying annual growth of 51.7%.
Current consensus DPS estimate is 10.9, implying a prospective dividend yield of 7.0%.
Current consensus EPS estimate suggests the PER is 5.7.

Market Sentiment: 0.3
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources


Wilsons rates ((BPT)) as Overweight (1) –

Beach Energy's September-quarter results met consensus' and Wilsons' forecasts, albeit on lower Otway sales and a lower than forecast gas price.

The company closed the quarter with $252m in cash, $557m in drawn debt and raised the debt facility by $320m to $920m

The broker expects Otway will pump out considerably more gas next year.

Overweight rating and $1.84 target price retained.

This report was published on October 26, 2023.

Target price is $1.84 Current Price is $1.54 Difference: $0.295
If BPT meets the Wilsons target it will return approximately 19% (excluding dividends, fees and charges).
Current consensus price target is $1.79, suggesting upside of 15.8%(ex-dividends)
The company's fiscal year ends in June.

Forecast for FY24:

Wilsons forecasts a full year FY24 dividend of 5.00 cents and EPS of 16.00 cents.
At the last closing share price the estimated dividend yield is 3.24%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 9.66.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 17.8, implying annual growth of 1.3%.
Current consensus DPS estimate is 4.5, implying a prospective dividend yield of 2.9%.
Current consensus EPS estimate suggests the PER is 8.7.

Forecast for FY25:

Wilsons forecasts a full year FY25 dividend of 8.00 cents and EPS of 29.60 cents.
At the last closing share price the estimated dividend yield is 5.18%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 5.22.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 27.0, implying annual growth of 51.7%.
Current consensus DPS estimate is 10.9, implying a prospective dividend yield of 7.0%.
Current consensus EPS estimate suggests the PER is 5.7.

Market Sentiment: 0.3
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

CCP    CREDIT CORP GROUP LIMITED

Business & Consumer Credit – Overnight Price: $12.07

Canaccord Genuity rates ((CCP)) as Hold (3) –

On balance, Canaccord Genuity derives more positives than negatives from Credit Corp's AGM trading update. Positives in Australia for the 1Q included materially stronger lending volumes, along with improving lending arrears.

Also, management confirmed guidance for FY24 free cash flow (FCF) generation, which appears 2H weighted to the analyst.

Importantly, suggests the broker, the company anticipates the net debt to equity metric will fall to 25% by June 2024, compared to 35% at the end of September this year.

The Hold rating and $13.20 target are retained.

This report was published on October 25, 2023.

Target price is $13.20 Current Price is $12.07 Difference: $1.13
If CCP meets the Canaccord Genuity target it will return approximately 9% (excluding dividends, fees and charges).
Current consensus price target is $15.02, suggesting upside of 22.9%(ex-dividends)
The company's fiscal year ends in June.

Forecast for FY24:

Canaccord Genuity forecasts a full year FY24 dividend of 48.00 cents and EPS of 120.00 cents.
At the last closing share price the estimated dividend yield is 3.98%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 10.06.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 79.4, implying annual growth of -40.8%.
Current consensus DPS estimate is 40.7, implying a prospective dividend yield of 3.3%.
Current consensus EPS estimate suggests the PER is 15.4.

Forecast for FY25:

Canaccord Genuity forecasts a full year FY25 dividend of 67.00 cents and EPS of 134.00 cents.
At the last closing share price the estimated dividend yield is 5.55%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 9.01.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 118.8, implying annual growth of 49.6%.
Current consensus DPS estimate is 60.3, implying a prospective dividend yield of 4.9%.
Current consensus EPS estimate suggests the PER is 10.3.

Market Sentiment: 0.5
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

CXL    CALIX LIMITED

Industrial Sector Contractors & Engineers – Overnight Price: $2.68

Canaccord Genuity rates ((CXL)) as Buy (1) –

Buy-rated Canaccord Genuity points out Calix continues to make operational progress and suggests the market is currently not pricing any future upside for the busines, which is largely exposed to the positive decarbonisation thematic.

Since 2021, the company has grown the Leilac pipeline, signing agreements with Heidelberg Cement and Cemex, and reached a final investment decision (FID) on the lithium midstream demonstration plant with Pilbara Minerals ((PLS)).

Largely as a result of adopting a higher discount rate, thanks to rising risk-free rates, the broker's target falls to $7.70 from $10.50.

This report was published on October 25, 2023.

Target price is $7.70 Current Price is $2.68 Difference: $5.02
If CXL meets the Canaccord Genuity target it will return approximately 187% (excluding dividends, fees and charges).

Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

EVS    ENVIROSUITE LIMITED

Industrial Sector Contractors & Engineers – Overnight Price: $0.06

Wilsons rates ((EVS)) as Overweight (1) –

EnviroSuite's September-quarter trading update appears to have fallen shy of Wilsons' forecasts, as one-off churn (which was steady) removed the gloss.

Management reiterated guidance that it will deliver positive adjusted earnings (EBITDA) less capitalised development costs on a run rate basis during FY24.

Wilsons says that while churn is inevitable in any business but says any reduction here will deliver a strong boost to the company's earnings.

Annual recurring revenue and sales were respectable and the company continued to post growth in the mining and industrial sector in Europe and North America. Management cited significant expansion in key airports.

Overweight rating retained, the broker observing the company is trading at a -80% discount to global peers. 

Target price falls -18% to 13c.

This report was published on October 26, 2023.

Target price is $0.13 Current Price is $0.06 Difference: $0.071
If EVS meets the Wilsons target it will return approximately 120% (excluding dividends, fees and charges).
The company's fiscal year ends in June.

Forecast for FY24:

Wilsons forecasts a full year FY24 dividend of 0.00 cents and EPS of minus 0.70 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is minus 8.43.

Forecast for FY25:

Wilsons forecasts a full year FY25 dividend of 0.00 cents and EPS of minus 0.40 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is minus 14.75.

Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

KGN    KOGAN.COM LIMITED

Retailing – Overnight Price: $4.38

Jarden rates ((KGN)) as Underweight (4) –

Kogan.com's September-quarter result appears to have met Jarden's forecasts and the broker views the expansion of the company's earnings (EBITDA) margin as encouraging.

EPS forecasts rise 14.5% for FY24; and 21% for FY25.

The broker believes the company has hit a top-line inflection point (which should allow it to push forward as macro headwinds ease) but observes sales growth remained modest in the quarter.

So Jarden stays its rating hand, retaining an Underweight rating and $4.50 target price.

This report was published on October 26, 2023.

Target price is $4.50 Current Price is $4.38 Difference: $0.12
If KGN meets the Jarden target it will return approximately 3% (excluding dividends, fees and charges).
Current consensus price target is $6.53, suggesting upside of 46.5%(ex-dividends)
The company's fiscal year ends in June.

Forecast for FY24:

Jarden forecasts a full year FY24 dividend of 0.00 cents and EPS of 9.40 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 46.60.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 12.2, implying annual growth of N/A.
Current consensus DPS estimate is 2.3, implying a prospective dividend yield of 0.5%.
Current consensus EPS estimate suggests the PER is 36.6.

Forecast for FY25:

Jarden forecasts a full year FY25 dividend of 0.00 cents and EPS of 13.20 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 33.18.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 30.6, implying annual growth of 150.8%.
Current consensus DPS estimate is 14.5, implying a prospective dividend yield of 3.3%.
Current consensus EPS estimate suggests the PER is 14.6.

Market Sentiment: -0.2
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

KLS    KELSIAN GROUP LIMITED

Transportation & Logistics – Overnight Price: $6.02

Canaccord Genuity rates ((KLS)) as Buy (1) –

Canaccord Genuity takes away from AGM commentary that management is "happy" with current trading across all three divisions, while costs for labour and overtime have largely normalised.

Management noted a large and active tender pipeline remains in place across both domestic and international markets.

The share price has fallen by -16% over the past four months, and Canaccord sees good value, especially with upside potential for the Marine & Tourism segment in summer as international visitors return.

The Buy rating and $7.60 target price are retained.

This report was published on October 25, 2023.

Target price is $7.60 Current Price is $6.02 Difference: $1.58
If KLS meets the Canaccord Genuity target it will return approximately 26% (excluding dividends, fees and charges).
Current consensus price target is $7.29, suggesting upside of 20.5%(ex-dividends)
The company's fiscal year ends in June.

Forecast for FY24:

Canaccord Genuity forecasts a full year FY24 dividend of 21.00 cents and EPS of 39.00 cents.
At the last closing share price the estimated dividend yield is 3.49%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 15.44.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 39.5, implying annual growth of 335.5%.
Current consensus DPS estimate is 20.6, implying a prospective dividend yield of 3.4%.
Current consensus EPS estimate suggests the PER is 15.3.

Forecast for FY25:

Canaccord Genuity forecasts a full year FY25 dividend of 24.00 cents and EPS of 44.00 cents.
At the last closing share price the estimated dividend yield is 3.99%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 13.68.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 43.8, implying annual growth of 10.9%.
Current consensus DPS estimate is 22.8, implying a prospective dividend yield of 3.8%.
Current consensus EPS estimate suggests the PER is 13.8.

Market Sentiment: 0.7
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

MFG    MAGELLAN FINANCIAL GROUP LIMITED

Wealth Management & Investments – Overnight Price: $6.49

Goldman Sachs rates ((MFG)) as Neutral (3) –

Magellan Financial's FY24 cost guidance rose edged higher due to retention payments for employees with outstanding ESPP loan balances, but remains below Goldman Sachs' forecasts.

The broker observes management intends to build a new employee alignment and accountability model by June to align incentives with client and shareholder outcomes.

The company's CEO David George has stepped down ahead of a December handover; a search for a new CEO is under way; and Andrew Formica steps into the executive chair.

Neutral rating and $7.55 target price retained.

This report was published on October 26, 2023.

Target price is $7.55 Current Price is $6.49 Difference: $1.06
If MFG meets the Goldman Sachs target it will return approximately 16% (excluding dividends, fees and charges).
Current consensus price target is $8.52, suggesting upside of 30.1%(ex-dividends)
The company's fiscal year ends in June.

Forecast for FY24:

Goldman Sachs forecasts a full year FY24 dividend of 52.00 cents and EPS of 75.00 cents.
At the last closing share price the estimated dividend yield is 8.01%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 8.65.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 75.7, implying annual growth of -24.3%.
Current consensus DPS estimate is 57.2, implying a prospective dividend yield of 8.7%.
Current consensus EPS estimate suggests the PER is 8.7.

Forecast for FY25:

Goldman Sachs forecasts a full year FY25 dividend of 35.80 cents and EPS of 58.00 cents.
At the last closing share price the estimated dividend yield is 5.52%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 11.19.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 68.1, implying annual growth of -10.0%.
Current consensus DPS estimate is 49.4, implying a prospective dividend yield of 7.5%.
Current consensus EPS estimate suggests the PER is 9.6.

Market Sentiment: 0.1
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

MIN    MINERAL RESOURCES LIMITED

Iron Ore – Overnight Price: $57.76

Goldman Sachs rates ((MIN)) as Sell (5) –

September quarter production for Mineral Resources was weaker than Goldman Sachs had anticipated.

Lower-than-forecast sales for lithium and iron ore, along with weaker lithium pricing were partly offset by better-than-expected iron ore pricing and a 14% quarter-on-quarter rebound in volumes for the Mining Services division, explains the broker.

Congestion arising from unscheduled port maintenance resulted in misses for spodumene shipments against forecasts by the broker and consensus of -24% and -19%, respectively. 

FY24 guidance was unchanged and the analyst feels growth projects are broadly on track, with the third processing plant at Wodgina
expected to be up and running this January.

The target falls to $51 from $53. Sell.

This report was published on October 26, 2023.

Target price is $51.00 Current Price is $57.76 Difference: minus $6.76 (current price is over target).
If MIN meets the Goldman Sachs target it will return approximately minus 12% (excluding dividends, fees and charges – negative figures indicate an expected loss).
Current consensus price target is $74.29, suggesting upside of 27.4%(ex-dividends)
The company's fiscal year ends in June.

Forecast for FY24:

Goldman Sachs forecasts a full year FY24 dividend of 134.00 cents and EPS of 268.00 cents.
At the last closing share price the estimated dividend yield is 2.32%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 21.55.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 358.1, implying annual growth of 181.1%.
Current consensus DPS estimate is 154.6, implying a prospective dividend yield of 2.7%.
Current consensus EPS estimate suggests the PER is 16.3.

Forecast for FY25:

Goldman Sachs forecasts a full year FY25 dividend of 42.00 cents and EPS of 60.00 cents.
At the last closing share price the estimated dividend yield is 0.73%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 96.27.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 782.6, implying annual growth of 118.5%.
Current consensus DPS estimate is 342.1, implying a prospective dividend yield of 5.9%.
Current consensus EPS estimate suggests the PER is 7.5.

Market Sentiment: 0.4
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources


Jarden rates ((MIN)) as Sell (5) –

Mineral Resources' September-quarter result proved a mixed bag. Jarden appreciates the jump in ore production at Wodgina and Mt Marion, but processing and logistics disappointed, with shipping the big miss. FY24 guidance was retained.

Spodumene production proved a miss, meaning Wodgina outpaced the broker's forecast, but Mt Marion disappointed.

Jarden expects weak September-quarter shipments can be recovered in the December quarter, albeit on a likely lower lithium price.

The broker considers Mineral Resources' commentary on lithium pricing to be intriguing. The company said pricing was not accurately reflecting market fundamentals. Manipulation, conjectures the broker, or just price discovery? Jarden goes with discovery.

EPS forecasts fall in FY24 and rise in FY25.

Sell rating retained. Target price rises to $50.30 from $47.30, to reflect capital invested in Onslow.

This report was published on October 26, 2023.

Target price is $50.30 Current Price is $57.76 Difference: minus $7.46 (current price is over target).
If MIN meets the Jarden target it will return approximately minus 13% (excluding dividends, fees and charges – negative figures indicate an expected loss).
Current consensus price target is $74.29, suggesting upside of 27.4%(ex-dividends)
The company's fiscal year ends in June.

Forecast for FY24:

Jarden forecasts a full year FY24 dividend of 100.00 cents and EPS of 227.00 cents.
At the last closing share price the estimated dividend yield is 1.73%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 25.44.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 358.1, implying annual growth of 181.1%.
Current consensus DPS estimate is 154.6, implying a prospective dividend yield of 2.7%.
Current consensus EPS estimate suggests the PER is 16.3.

Forecast for FY25:

Jarden forecasts a full year FY25 dividend of 60.00 cents and EPS of 238.00 cents.
At the last closing share price the estimated dividend yield is 1.04%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 24.27.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 782.6, implying annual growth of 118.5%.
Current consensus DPS estimate is 342.1, implying a prospective dividend yield of 5.9%.
Current consensus EPS estimate suggests the PER is 7.5.

Market Sentiment: 0.4
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

MPL    MEDIBANK PRIVATE LIMITED

Insurance – Overnight Price: $3.43

Jarden rates ((MPL)) as Overweight (2) –

Jarden looks to APRA's Operations of Private Health Insurers for a read-through to Medibank Private.

The broker observes that not-for-profit policies hit their highest levels since FY18 due to Medibank's cybercrime incident; the industry is recording record gross margins (aided by covid provision releases) thanks to record Hospital margins and Extras hitting record lows.

Net margins declined to reflect higher costs, particularly among not-for-profits.

Bupa and Medibank Private logged gains in overseas student vistor PHI market share at the expense of nib Holdings ((NHF)), a sector where premiums grew 40%.

All up, the broker spies room for for-profits to lift market share. Overweight rating returned. Target price is $3.75.

This report was published on October 26, 2023.

Target price is $3.75 Current Price is $3.43 Difference: $0.32
If MPL meets the Jarden target it will return approximately 9% (excluding dividends, fees and charges).
Current consensus price target is $3.78, suggesting upside of 11.2%(ex-dividends)
The company's fiscal year ends in June.

Forecast for FY24:

Jarden forecasts a full year FY24 dividend of 16.10 cents and EPS of 19.10 cents.
At the last closing share price the estimated dividend yield is 4.69%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 17.96.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 19.9, implying annual growth of 7.2%.
Current consensus DPS estimate is 15.9, implying a prospective dividend yield of 4.7%.
Current consensus EPS estimate suggests the PER is 17.1.

Forecast for FY25:

Jarden forecasts a full year FY25 dividend of 17.20 cents and EPS of 21.40 cents.
At the last closing share price the estimated dividend yield is 5.01%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 16.03.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 20.6, implying annual growth of 3.5%.
Current consensus DPS estimate is 17.0, implying a prospective dividend yield of 5.0%.
Current consensus EPS estimate suggests the PER is 16.5.

Market Sentiment: 0.2
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

NHF    NIB HOLDINGS LIMITED

Insurance – Overnight Price: $7.24

Jarden rates ((NHF)) as Neutral (3) –

Jarden looks to APRA's Operations of Private Health Insurers for a read-through to nib Holdings. Bupa and nib Holdingsposted strong solid market share gains.

But the broker observes that not-for-profit policies hit their highest levels since FY18 due to Medibank's ((MPL)) cybercrime incident.

The industry is recording record gross margins (aided by covid provision releases) thanks to record Hospital margins and Extras hitting record lows.

Net margins declined to reflect higher costs, particularly among not-for-profits.

Bupa and Medibank Private logged gains in overseas student visitor PHI market share at the expense of nib Holdings, a sector in which premiums grew 40%.

All up, the broker spies room for for-profits to lift market share.

Neutral rating retained. Target price is $8.

This report was published on October 26, 2023.

Target price is $8.00 Current Price is $7.24 Difference: $0.76
If NHF meets the Jarden target it will return approximately 10% (excluding dividends, fees and charges).
Current consensus price target is $8.40, suggesting upside of 16.1%(ex-dividends)
The company's fiscal year ends in June.

Forecast for FY24:

Jarden forecasts a full year FY24 dividend of 29.00 cents and EPS of 42.30 cents.
At the last closing share price the estimated dividend yield is 4.01%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 17.12.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 45.4, implying annual growth of 9.6%.
Current consensus DPS estimate is 29.7, implying a prospective dividend yield of 4.1%.
Current consensus EPS estimate suggests the PER is 15.9.

Forecast for FY25:

Jarden forecasts a full year FY25 dividend of 30.00 cents and EPS of 45.40 cents.
At the last closing share price the estimated dividend yield is 4.14%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 15.95.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 47.9, implying annual growth of 5.5%.
Current consensus DPS estimate is 31.2, implying a prospective dividend yield of 4.3%.
Current consensus EPS estimate suggests the PER is 15.1.

Market Sentiment: 0.0
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

PBH    POINTSBET HOLDINGS LIMITED

Gaming – Overnight Price: $0.76

Jarden rates ((PBH)) as Buy (1) –

PointsBet Holdings's September-quarter result pleased Jarden, thanks to a focus on Australia, where trading margins marched back towards the long-term average.

All up, the broker considered it a respectable performance given market weakness, despite operating cash outflows.

Management guided to positive cash outflows for the final three quarters of FY24 (a first, observes the broker), and profitability by 2025.

The sale of the US business is on track, notes Jarden.

Buy rating retained. Target price rises to 94c from 90c in anticipation of a capital return.

This report was published on October 26, 2023.

Target price is $0.94 Current Price is $0.76 Difference: $0.185
If PBH meets the Jarden target it will return approximately 25% (excluding dividends, fees and charges).
The company's fiscal year ends in June.

Forecast for FY24:

Jarden forecasts a full year FY24 dividend of 0.00 cents and EPS of minus 5.90 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is minus 12.80.

Forecast for FY25:

Jarden forecasts a full year FY25 EPS of 2.10 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 35.95.

Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

PME    PRO MEDICUS LIMITED

Medical Equipment & Devices – Overnight Price: $74.54

Moelis rates ((PME)) as Hold (3) –

Moelis increases its 12-month target price for Pro Medicus to $79.06 from $72.19 after incorporating two recent contract wins in the US into forecasts.

The company secured a $140m contract over ten years with one of the largest not-for-profit healthcare systems in the US, Baylor
Scott & White Health. An eight-year $16m contract with mid-sized IDN, South Shore Health, was also more recently won.

In reference to this latter contract, the company noted cloud-based deployment is opening up the mid-sized market and expanding the pool of potential customers.

Management also relayed the "pipeline remains strong and spans all market segments," with the trend towards customers opting for the full-stack of products continuing.

As good as the above sounds, Moelis retains its Hold rating as the price earnings ratio of more than 100 times currently captures not only good management by Pro Medicus, but also the long runway of growth.

This report was published on October 26, 2023.

Target price is $79.06 Current Price is $74.54 Difference: $4.52
If PME meets the Moelis target it will return approximately 6% (excluding dividends, fees and charges).
Current consensus price target is $63.88, suggesting downside of -16.8%(ex-dividends)
The company's fiscal year ends in June.

Forecast for FY24:

Moelis forecasts a full year FY24 dividend of 38.00 cents and EPS of 76.70 cents.
At the last closing share price the estimated dividend yield is 0.51%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 97.18.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 76.3, implying annual growth of 31.3%.
Current consensus DPS estimate is 38.6, implying a prospective dividend yield of 0.5%.
Current consensus EPS estimate suggests the PER is 100.6.

Forecast for FY25:

Moelis forecasts a full year FY25 dividend of 44.00 cents and EPS of 93.60 cents.
At the last closing share price the estimated dividend yield is 0.59%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 79.64.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 99.5, implying annual growth of 30.4%.
Current consensus DPS estimate is 49.8, implying a prospective dividend yield of 0.6%.
Current consensus EPS estimate suggests the PER is 77.2.

Market Sentiment: -0.3
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

PRU    PERSEUS MINING LIMITED

Gold & Silver – Overnight Price: $1.71

Canaccord Genuity rates ((PRU)) as Buy (1) –

Production and costs in the 1Q for Perseus Mining were better than both Canaccord Genuity and consensus had anticipated thanks to better-than-expected grades/throughput at the Yaoure gold mine in Cote d'Ivoire.

Lower waste movements/unit costs helped deliver US$667/oz in costs (AISC) compared to the US$953/oz anticipated by consensus, which more than offset weather-affected Sissingue operations, also in Cote d'Ivoire. 

Production for Edikan (in Ghana) was in line with the broker's forecasts while costs were 9% better-than-forecast.

Canaccord believes the upper range of 1H production and cost guidance will be easily reached and maintains a Buy rating. The $2.30 target is unchanged.

This report was published on October 25, 2023.

Target price is $2.30 Current Price is $1.71 Difference: $0.595
If PRU meets the Canaccord Genuity target it will return approximately 35% (excluding dividends, fees and charges).
The company's fiscal year ends in June.

Forecast for FY24:

Canaccord Genuity forecasts a full year FY24 dividend of 4.00 cents and EPS of 30.00 cents.
At the last closing share price the estimated dividend yield is 2.35%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 5.68.

Forecast for FY25:

Canaccord Genuity forecasts a full year FY25 dividend of 2.00 cents and EPS of 27.00 cents.
At the last closing share price the estimated dividend yield is 1.17%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 6.31.

Market Sentiment: 0.5
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

QBE    QBE INSURANCE GROUP LIMITED

Insurance – Overnight Price: $15.60

Goldman Sachs rates ((QBE)) as Buy (1) –

Goldman Sachs reviews Chubb Ltd's 3Q results to glean any potential conclusions for the North American business of QBE Insurance.

The broker believes the ongoing strong rate in commercial should bode favourably for QBE Insurance, consistent with the recent trading update by US-based Travelers.

Chubb noted rate trends were ahead of loss cost inflation, which the analysts note is a positive read through for margins to the extent CAT/reinsurance cost pressures can be offset.

The $18.09 target and Buy rating are unchanged.

This report was published on October 31, 2023.

Target price is $18.09 Current Price is $15.60 Difference: $2.49
If QBE meets the Goldman Sachs target it will return approximately 16% (excluding dividends, fees and charges).
Current consensus price target is $17.14, suggesting upside of 9.5%(ex-dividends)
The company's fiscal year ends in December.

Forecast for FY23:

Goldman Sachs forecasts a full year FY23 dividend of 90.98 cents and EPS of 182.26 cents.
At the last closing share price the estimated dividend yield is 5.83%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 8.56.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 141.8, implying annual growth of N/A.
Current consensus DPS estimate is 103.0, implying a prospective dividend yield of 6.6%.
Current consensus EPS estimate suggests the PER is 11.0.

Forecast for FY24:

Goldman Sachs forecasts a full year FY24 dividend of 129.99 cents and EPS of 189.79 cents.
At the last closing share price the estimated dividend yield is 8.33%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 8.22.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 188.4, implying annual growth of 32.9%.
Current consensus DPS estimate is 127.2, implying a prospective dividend yield of 8.1%.
Current consensus EPS estimate suggests the PER is 8.3.

This company reports in USD. All estimates have been converted into AUD by FNArena at present FX values.
Market Sentiment: 0.8
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

REG    REGIS HEALTHCARE LIMITED

Aged Care & Seniors – Overnight Price: $2.50

Jarden rates ((REG)) as Overweight (2) –

Earnings forecast upgrades by Jarden for Regis Healthcare following a 1Q AGM update are offset by a higher risk-free rate assumption, and the target slips to $2.87 from $2.95.

The broker notes improving trends across government revenue, occupancy and resident care minutes. Average government revenue per occupied bed of $279.60 is tracking 1.6% ahead of the analysts' 1H forecast and 3.6% ahead of the consensus estimate.

Occupancy was 93.5% for the 1Q, up from 92.5% in the prior quarter, while care minutes rose to 187 minutes from 179 minutes.

The Overweight rating is maintained.

This report was published on October 25, 2023.

Target price is $2.87 Current Price is $2.50 Difference: $0.37
If REG meets the Jarden target it will return approximately 15% (excluding dividends, fees and charges).
The company's fiscal year ends in June.

Forecast for FY24:

Jarden forecasts a full year FY24 dividend of 4.00 cents and EPS of 9.00 cents.
At the last closing share price the estimated dividend yield is 1.60%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 27.78.

Forecast for FY25:

Jarden forecasts a full year FY25 dividend of 4.00 cents and EPS of 10.70 cents.
At the last closing share price the estimated dividend yield is 1.60%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 23.36.

Market Sentiment: 0.8
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

RGN    REGION GROUP

REITs – Overnight Price: $1.97

Moelis rates ((RGN)) as Buy (1) –

Region Group released 1Q results at its AGM showing a 2.8% year-on-year sales increase, which prompts Moelis to suggest the company's shares are trading in deep-value territory. The group's assets are expected to benefit because of their defensive characteristics.

Sales for supermarkets and non-discretionary specialties rose by 3.6% and 4.1%, respectively, while discretionary specialties experienced a -2.9% fall.

The broker makes only minor forecast changes on higher interest rate assumptions, but notes the group is more than 60% hedged against interest rate rises over the next three years.

The target eases to $2.66 from $2.67. Buy.

This report was published on October 26, 2023.

Target price is $2.66 Current Price is $1.97 Difference: $0.695
If RGN meets the Moelis target it will return approximately 35% (excluding dividends, fees and charges).
Current consensus price target is $2.41, suggesting upside of 21.9%(ex-dividends)
The company's fiscal year ends in June.

Forecast for FY24:

Moelis forecasts a full year FY24 dividend of 13.70 cents and EPS of 15.60 cents.
At the last closing share price the estimated dividend yield is 6.97%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 12.60.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 15.5, implying annual growth of N/A.
Current consensus DPS estimate is 13.8, implying a prospective dividend yield of 7.0%.
Current consensus EPS estimate suggests the PER is 12.8.

Forecast for FY25:

Moelis forecasts a full year FY25 dividend of 13.80 cents and EPS of 15.70 cents.
At the last closing share price the estimated dividend yield is 7.02%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 12.52.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 15.5, implying annual growth of N/A.
Current consensus DPS estimate is 13.8, implying a prospective dividend yield of 7.0%.
Current consensus EPS estimate suggests the PER is 12.8.

Market Sentiment: 0.2
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

SUL    SUPER RETAIL GROUP LIMITED

Automobiles & Components – Overnight Price: $13.18

Goldman Sachs rates ((SUL)) as Buy (1) –

Super Retail's 16-week trading update revealed an acceleration in sales growth across all segments through to exit.

Goldman Sachs expects auto and sports will prove the most resilient of the discretionary spend categories, and says this works well for Super Retail which also enjoys resilience through its members, which constitute more than 70% of group sales.

Earnings forecasts rise a touch. Buy rating and $14.40 target price retained.

This report was published on October 26, 2023.

Target price is $14.40 Current Price is $13.18 Difference: $1.22
If SUL meets the Goldman Sachs target it will return approximately 9% (excluding dividends, fees and charges).
Current consensus price target is $12.38, suggesting downside of -5.0%(ex-dividends)
The company's fiscal year ends in June.

Forecast for FY24:

Goldman Sachs forecasts a full year FY24 dividend of 62.00 cents and EPS of 95.00 cents.
At the last closing share price the estimated dividend yield is 4.70%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 13.87.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 97.0, implying annual growth of -16.7%.
Current consensus DPS estimate is 70.4, implying a prospective dividend yield of 5.4%.
Current consensus EPS estimate suggests the PER is 13.4.

Forecast for FY25:

Goldman Sachs forecasts a full year FY25 dividend of 64.00 cents and EPS of 98.00 cents.
At the last closing share price the estimated dividend yield is 4.86%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 13.45.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 101.4, implying annual growth of 4.5%.
Current consensus DPS estimate is 70.2, implying a prospective dividend yield of 5.4%.
Current consensus EPS estimate suggests the PER is 12.9.

Market Sentiment: -0.2
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources


Jarden rates ((SUL)) as Underweight (4) –

Super Retail's 16-week AGM trading update outpaced Jarden's forecast, the run-rate accelerating into exit, thanks to exclusive ranging, good weather and a steadying in the macro environement, trends the broker expects will continue.

The broker appreciates the company's balance-sheet options, market share gains, gains in online penetration, improved margins and investment in data.

Jarden observes the company is building a competitive moat, aided by scale.

EPS forecasts rise 6% for FY24.

Jarden raises its rating to Neutral from Underweight. Target price rises to $12.90 from $12.60.

This report was published on October 25, 2023.

Target price is $12.60 Current Price is $13.18 Difference: minus $0.58 (current price is over target).
If SUL meets the Jarden target it will return approximately minus 4% (excluding dividends, fees and charges – negative figures indicate an expected loss).
Current consensus price target is $12.38, suggesting downside of -5.0%(ex-dividends)
The company's fiscal year ends in June.

Forecast for FY24:

Jarden forecasts a full year FY24 dividend of 63.00 cents and EPS of 98.80 cents.
At the last closing share price the estimated dividend yield is 4.78%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 13.34.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 97.0, implying annual growth of -16.7%.
Current consensus DPS estimate is 70.4, implying a prospective dividend yield of 5.4%.
Current consensus EPS estimate suggests the PER is 13.4.

Forecast for FY25:

Jarden forecasts a full year FY25 dividend of 62.00 cents and EPS of 95.70 cents.
At the last closing share price the estimated dividend yield is 4.70%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 13.77.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 101.4, implying annual growth of 4.5%.
Current consensus DPS estimate is 70.2, implying a prospective dividend yield of 5.4%.
Current consensus EPS estimate suggests the PER is 12.9.

Market Sentiment: -0.2
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources


Wilsons rates ((SUL)) as Market Weight (3) –

Super Retail's AGM 16-week trading update revealed strong trading across the business, outpacing Wilsons' forecasts.

The broker still expects a weaker Christmas but says consistent gross margins and focus on the cost of doing business should reduce pressure on the profit before tax line. 

Market Weight rating retained on valuation. Target price is $12.70.

This report was published on October 26, 2023.

Target price is $12.70 Current Price is $13.18 Difference: minus $0.48 (current price is over target).
If SUL meets the Wilsons target it will return approximately minus 4% (excluding dividends, fees and charges – negative figures indicate an expected loss).
Current consensus price target is $12.38, suggesting downside of -5.0%(ex-dividends)
The company's fiscal year ends in June.

Forecast for FY24:

Wilsons forecasts a full year FY24 dividend of 74.40 cents and EPS of 98.00 cents.
At the last closing share price the estimated dividend yield is 5.64%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 13.45.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 97.0, implying annual growth of -16.7%.
Current consensus DPS estimate is 70.4, implying a prospective dividend yield of 5.4%.
Current consensus EPS estimate suggests the PER is 13.4.

Forecast for FY25:

Wilsons forecasts a full year FY25 dividend of 77.00 cents and EPS of 101.90 cents.
At the last closing share price the estimated dividend yield is 5.84%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 12.93.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 101.4, implying annual growth of 4.5%.
Current consensus DPS estimate is 70.2, implying a prospective dividend yield of 5.4%.
Current consensus EPS estimate suggests the PER is 12.9.

Market Sentiment: -0.2
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

WOW    WOOLWORTHS GROUP LIMITED

Food, Beverages & Tobacco – Overnight Price: $35.22

Goldman Sachs rates ((WOW)) as Buy (1) –

Woolworths Group's September-quarter appears to align with most Australian food indicators, observes Goldman Sachs, noting quality indicators suggest gross profit margins are fairing well.

New Zealand could prove more challenging, says the broker.

Food volumes were strong and signs are positive heading into Christmas, observes Goldman Sachs.

Buy rating reiterated. Target price edges up to $42.40 from $42.

This report was published on October 26, 2023.

Target price is $42.40 Current Price is $35.22 Difference: $7.18
If WOW meets the Goldman Sachs target it will return approximately 20% (excluding dividends, fees and charges).
Current consensus price target is $36.77, suggesting upside of 4.9%(ex-dividends)
The company's fiscal year ends in June.

Forecast for FY24:

Goldman Sachs forecasts a full year FY24 dividend of 112.00 cents and EPS of 149.00 cents.
At the last closing share price the estimated dividend yield is 3.18%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 23.64.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 149.2, implying annual growth of 12.0%.
Current consensus DPS estimate is 112.3, implying a prospective dividend yield of 3.2%.
Current consensus EPS estimate suggests the PER is 23.5.

Forecast for FY25:

Goldman Sachs forecasts a full year FY25 dividend of 123.00 cents and EPS of 163.00 cents.
At the last closing share price the estimated dividend yield is 3.49%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 21.61.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 158.4, implying annual growth of 6.2%.
Current consensus DPS estimate is 118.8, implying a prospective dividend yield of 3.4%.
Current consensus EPS estimate suggests the PER is 22.1.

Market Sentiment: 0.2
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources


Jarden rates ((WOW)) as Overweight (2) –

Woolworths Group's September-quarter trading update largely met Jarden's forecasts, with food outpacing and NZ proving a miss.

EPS forecasts rise 2.5% in FY24, with improvements in food sales expected to outweigh weakness in New Zealand and Big W.

The broker forecasts a 6% EPS compound annual growth rate across FY24 to FY27.

Metcash ((MTS)) is the broker's top sector pick, with Woolworths taking second prize.

Overweight rating retained. Target price falls to $42.60 from $43.10 to reflect forecasts earnings cuts and higher risk-free rates.

This report was published on October 26, 2023.

Target price is $42.60 Current Price is $35.22 Difference: $7.38
If WOW meets the Jarden target it will return approximately 21% (excluding dividends, fees and charges).
Current consensus price target is $36.77, suggesting upside of 4.9%(ex-dividends)
The company's fiscal year ends in June.

Forecast for FY24:

Jarden forecasts a full year FY24 dividend of 119.00 cents and EPS of 158.40 cents.
At the last closing share price the estimated dividend yield is 3.38%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 22.23.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 149.2, implying annual growth of 12.0%.
Current consensus DPS estimate is 112.3, implying a prospective dividend yield of 3.2%.
Current consensus EPS estimate suggests the PER is 23.5.

Forecast for FY25:

Jarden forecasts a full year FY25 dividend of 123.00 cents and EPS of 164.80 cents.
At the last closing share price the estimated dividend yield is 3.49%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 21.37.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 158.4, implying annual growth of 6.2%.
Current consensus DPS estimate is 118.8, implying a prospective dividend yield of 3.4%.
Current consensus EPS estimate suggests the PER is 22.1.

Market Sentiment: 0.2
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources


Disclaimer:
The content of this information does in no way reflect the opinions of FNArena, or of its journalists. In fact we don't have any opinion about the stock market, its value, future direction or individual shares. FNArena solely reports about what the main experts in the market note, believe and comment on. By doing so we believe we provide experienced, intelligent investors with a valuable tool that helps them in making up their own minds, reading market trends and getting a feel for what is happening beneath the surface.

This document is provided for informational purposes only. It does not constitute an offer to sell or a solicitation to buy any security or other financial instrument. FNArena employs very experienced journalists who base their work on information believed to be reliable and accurate, though no guarantee is given that the daily report is accurate or complete. Investors should contact their personal adviser before making any investment decision.

Decisions about inclusions in this Report are made independently of the providers of stock market research and at full discretion of the team of journalists responsible for content at FNArena. Inclusion does not equal endorsement, in any way, shape or form. This Report is provided for informational purposes only.

Share on FacebookTweet about this on TwitterShare on LinkedIn

Click to view our Glossary of Financial Terms

CHARTS

29M AND BPT CCP CXL EVS KGN KLS MFG MIN MPL MTS NHF PBH PLS PME PRU QBE REG RGN SUL WOW

For more info SHARE ANALYSIS: 29M - 29METALS LIMITED

For more info SHARE ANALYSIS: AND - ANSARADA GROUP LIMITED

For more info SHARE ANALYSIS: BPT - BEACH ENERGY LIMITED

For more info SHARE ANALYSIS: CCP - CREDIT CORP GROUP LIMITED

For more info SHARE ANALYSIS: CXL - CALIX LIMITED

For more info SHARE ANALYSIS: EVS - ENVIROSUITE LIMITED

For more info SHARE ANALYSIS: KGN - KOGAN.COM LIMITED

For more info SHARE ANALYSIS: KLS - KELSIAN GROUP LIMITED

For more info SHARE ANALYSIS: MFG - MAGELLAN FINANCIAL GROUP LIMITED

For more info SHARE ANALYSIS: MIN - MINERAL RESOURCES LIMITED

For more info SHARE ANALYSIS: MPL - MEDIBANK PRIVATE LIMITED

For more info SHARE ANALYSIS: MTS - METCASH LIMITED

For more info SHARE ANALYSIS: NHF - NIB HOLDINGS LIMITED

For more info SHARE ANALYSIS: PBH - POINTSBET HOLDINGS LIMITED

For more info SHARE ANALYSIS: PLS - PILBARA MINERALS LIMITED

For more info SHARE ANALYSIS: PME - PRO MEDICUS LIMITED

For more info SHARE ANALYSIS: PRU - PERSEUS MINING LIMITED

For more info SHARE ANALYSIS: QBE - QBE INSURANCE GROUP LIMITED

For more info SHARE ANALYSIS: REG - REGIS HEALTHCARE LIMITED

For more info SHARE ANALYSIS: RGN - REGION GROUP

For more info SHARE ANALYSIS: SUL - SUPER RETAIL GROUP LIMITED

For more info SHARE ANALYSIS: WOW - WOOLWORTHS GROUP LIMITED